Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease.

Janssen JAMJL, Varewijck AJ, Brugts MP.

Growth Horm IGF Res. 2019 Aug 21;48-49:16-28. doi: 10.1016/j.ghir.2019.08.001. [Epub ahead of print] Review.

PMID:
31493625
2.

Diagnosing Metabolic Syndrome in Craniopharyngioma Patients: Body Composition versus BMI.

van Santen SS, Olsson DS, Hammarstrand C, Wijnen M, van den Heuvel-Eibrink MM, Van der Lely AJ, Johannsson G, Janssen JAMJL, Neggers SJCMM.

Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0181.R1. doi: 10.1530/EJE-19-0181. [Epub ahead of print]

PMID:
31167166
3.

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.

De Martino MC, van Koetsveld PM, Feelders RA, de Herder WW, Dogan F, Janssen JAMJL, Hofste Op Bruinink D, Pivonello C, Waaijers AM, Colao A, de Krijger RR, Pivonello R, Hofland LJ.

Endocrine. 2019 Jun;64(3):673-684. doi: 10.1007/s12020-019-01869-1. Epub 2019 Mar 5.

4.

Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer's Disease.

Galle SA, van der Spek A, Drent ML, Brugts MP, Scherder EJA, Janssen JAMJL, Ikram MA, van Duijn CM.

Front Aging Neurosci. 2019 Feb 12;11:20. doi: 10.3389/fnagi.2019.00020. eCollection 2019.

5.

How to Position Pasireotide LAR Treatment in Acromegaly.

Coopmans EC, Muhammad A, van der Lely AJ, Janssen JAMJL, Neggers SJCMM.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):1978-1988. doi: 10.1210/jc.2018-01979.

PMID:
30608534
6.

Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression.

Muhammad A, Coopmans EC, Gatto F, Franck SE, Janssen JAMJL, van der Lely AJ, Hofland LJ, Neggers SJCMM.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):915-924. doi: 10.1210/jc.2018-01524.

PMID:
30346538
7.

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Smith TJ, Janssen JAMJL.

Endocr Rev. 2019 Feb 1;40(1):236-267. doi: 10.1210/er.2018-00066. Review.

PMID:
30215690
8.

Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study.

Muhammad A, Coopmans EC, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, van der Lely AJ, Neggers SJCMM.

Eur J Endocrinol. 2018 Oct 12;179(5):269-277. doi: 10.1530/EJE-18-0353.

PMID:
30076159
9.

An External Focus of Attention is Effective for Balance Control when Sleep-deprived.

Diekfuss JA, Janssen JA, Slutsky AB, Berry NT, Etnier JL, Wideman L, Raisbeck LD.

Int J Exerc Sci. 2018 Jun 1;11(5):84-94. eCollection 2018.

10.

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms.

de Graav GN, van der Zwan M, Baan CC, Janssen JAMJL, Hesselink DA.

Transplant Direct. 2018 Feb 20;4(3):e350. doi: 10.1097/TXD.0000000000000767. eCollection 2018 Mar.

11.

Genetic influence on the associations between IGF-I and glucose metabolism in a cohort of elderly twins.

Jensen RB, Thankamony A, Holst KK, Janssen JAMJL, Juul A, Dunger D, Poulsen P, Scheike T.

Eur J Endocrinol. 2018 Feb;178(2):153-161. doi: 10.1530/EJE-17-0754. Epub 2017 Dec 5.

PMID:
29208737
12.

Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study).

Muhammad A, van der Lely AJ, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, Neggers SJCMM.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):586-595. doi: 10.1210/jc.2017-02017.

PMID:
29155991
13.

Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):93-102. doi: 10.1530/EJE-17-0707. Epub 2017 Oct 18.

PMID:
29046325
14.

Disagreement in normative IGF-I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiency.

Varewijck AJ, van der Lely AJ, Neggers SJCMM, Hofland LJ, Janssen JAMJL.

Clin Endocrinol (Oxf). 2018 Mar;88(3):409-414. doi: 10.1111/cen.13491. Epub 2017 Oct 24.

PMID:
28977695
15.
16.

Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 Diabetes.

Janssen JAMJL, Llauradó G, Varewijck AJ, Groop PH, Forsblom C, Fernández-Veledo S, van den Dungen ESR, Vendrell J, Hofland LJ, Yki-Järvinen H.

J Clin Endocrinol Metab. 2017 Oct 1;102(10):3814-3821. doi: 10.1210/jc.2017-00892.

PMID:
28938465
17.

The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):11-22. doi: 10.1530/EJE-17-0387. Epub 2017 Sep 7.

PMID:
28882980
18.

Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747).

Smith TJ, Janssen JAMJL.

Thyroid. 2017 Nov;27(11):1458-1459. doi: 10.1089/thy.2017.0281. Epub 2017 Sep 28. No abstract available.

19.

The effects of low-intensity cycling on cognitive performance following sleep deprivation.

Slutsky AB, Diekfuss JA, Janssen JA, Berry NT, Shih CH, Raisbeck LD, Wideman L, Etnier JL.

Physiol Behav. 2017 Oct 15;180:25-30. doi: 10.1016/j.physbeh.2017.07.033. Epub 2017 Aug 9.

PMID:
28803119
20.

Very long-term sequelae of craniopharyngioma.

Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM.

Eur J Endocrinol. 2017 Jun;176(6):755-767. doi: 10.1530/EJE-17-0044. Epub 2017 Mar 21.

PMID:
28325825
21.

Vagal Regulation of Cardiac Function in Early Childhood and Cardiovascular Risk in Adolescence.

Gangel MJ, Shanahan L, Kolacz J, Janssen JA, Brown A, Calkins SD, Keane SP, Wideman L.

Psychosom Med. 2017 Jul/Aug;79(6):614-621. doi: 10.1097/PSY.0000000000000458.

22.

Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.

Smith TJ, Janssen JA.

Front Endocrinol (Lausanne). 2017 Jan 3;7:167. doi: 10.3389/fendo.2016.00167. eCollection 2016. Review.

23.

Childhood temperament predictors of adolescent physical activity.

Janssen JA, Kolacz J, Shanahan L, Gangel MJ, Calkins SD, Keane SP, Wideman L.

BMC Public Health. 2017 Jan 5;17(1):8. doi: 10.1186/s12889-016-3998-5.

24.

Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Wallenius V, Janssen JA, Delhanty PJ, van der Lely AJ, Johannsson G, Neggers SJ.

Int J Obes (Lond). 2017 Feb;41(2):210-216. doi: 10.1038/ijo.2016.195. Epub 2016 Oct 31.

PMID:
27795552
25.

Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.

Creemers SG, van Koetsveld PM, van Kemenade FJ, Papathomas TG, Franssen GJ, Dogan F, Eekhoff EM, van der Valk P, de Herder WW, Janssen JA, Feelders RA, Hofland LJ.

Endocr Relat Cancer. 2016 Sep;23(9):727-37. doi: 10.1530/ERC-16-0266.

PMID:
27535174
26.

Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.

Franck SE, Gatto F, van der Lely AJ, Janssen JAMJL, Dallenga AHG, Nagtegaal AP, Hofland LJ, Neggers SJCMM.

Neuroendocrinology. 2017;105(1):44-53. doi: 10.1159/000448429. Epub 2016 Jul 25.

27.

Impact of Physical Exercise on Endocrine Aging.

Janssen JA.

Front Horm Res. 2016;47:68-81. doi: 10.1159/000445158. Epub 2016 Jun 27. Review.

PMID:
27348867
28.

Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits.

Teumer A, Qi Q, Nethander M, Aschard H, Bandinelli S, Beekman M, Berndt SI, Bidlingmaier M, Broer L; CHARGE Longevity Working Group, Cappola A, Ceda GP, Chanock S, Chen MH, Chen TC, Chen YD, Chung J, Del Greco Miglianico F, Eriksson J, Ferrucci L, Friedrich N, Gnewuch C, Goodarzi MO, Grarup N, Guo T, Hammer E, Hayes RB, Hicks AA, Hofman A, Houwing-Duistermaat JJ, Hu F, Hunter DJ, Husemoen LL, Isaacs A, Jacobs KB, Janssen JA, Jansson JO, Jehmlich N, Johnson S, Juul A, Karlsson M, Kilpelainen TO, Kovacs P, Kraft P, Li C, Linneberg A, Liu Y, Loos RJ; Body Composition Genetics Consortium, Lorentzon M, Lu Y, Maggio M, Magi R, Meigs J, Mellström D, Nauck M, Newman AB, Pollak MN, Pramstaller PP, Prokopenko I, Psaty BM, Reincke M, Rimm EB, Rotter JI, Saint Pierre A, Schurmann C, Seshadri S, Sjögren K, Slagboom PE, Strickler HD, Stumvoll M, Suh Y, Sun Q, Zhang C, Svensson J, Tanaka T, Tare A, Tönjes A, Uh HW, van Duijn CM, van Heemst D, Vandenput L, Vasan RS, Völker U, Willems SM, Ohlsson C, Wallaschofski H, Kaplan RC.

Aging Cell. 2016 Oct;15(5):811-24. doi: 10.1111/acel.12490. Epub 2016 Jun 21. Erratum in: Aging Cell. 2017 Aug;16(4):898.

29.

Rationale, design and methods for the RIGHT Track Health Study: pathways from childhood self-regulation to cardiovascular risk in adolescence.

Wideman L, Calkins SD, Janssen JA, Lovelady CA, Dollar JM, Keane SP, Perrin EM, Shanahan L.

BMC Public Health. 2016 Jun 1;16:459. doi: 10.1186/s12889-016-3133-7.

30.

Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations.

Janssen JA, Hofland LJ, Strasburger CJ, van den Dungen ES, Thevis M.

PLoS One. 2016 Mar 18;11(3):e0150453. doi: 10.1371/journal.pone.0150453. eCollection 2016.

31.

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.

Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak M, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE.

Cancer Res. 2016 Apr 15;76(8):2288-2300. doi: 10.1158/0008-5472.CAN-15-1551. Epub 2016 Feb 26.

32.

What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?

Muhammad A, van der Lely AJ, O'Connor RD, Delhanty PJ, Dal J, Dallenga AH, Feelders RA, Janssen JA, Jorgensen JO, Neggers SJ.

Eur J Endocrinol. 2016 May;174(5):663-7. doi: 10.1530/EJE-15-1150. Epub 2016 Feb 22.

PMID:
26903550
33.

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells.

van Adrichem RC, de Herder WW, Kamp K, Brugts MP, de Krijger RR, Sprij-Mooij DM, Lamberts SW, van Koetsveld PM, Janssen JA, Hofland LJ.

Neuroendocrinology. 2016;103(6):815-25. doi: 10.1159/000444280. Epub 2016 Feb 2.

34.
35.

IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells.

Booy S, van Eijck CH, Janssen JA, Dogan F, van Koetsveld PM, Hofland LJ.

Am J Cancer Res. 2015 May 15;5(6):2035-46. eCollection 2015.

36.

Assessing Walking Activity in Older Adults: Development and Validation of a Novel Computer-Animated Assessment Tool.

Marsh AP, Janssen JA, Ip EH, Barnard RT, Ambrosius WT, Brubaker PR, Burdette JH, Sheedy JL, Rejeski WJ.

J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1555-61. doi: 10.1093/gerona/glv101. Epub 2015 Aug 10.

37.

Correction: An Early Diagnostic Tool for Diabetic Peripheral Neuropathy in Rats.

Kambiz S, van Neck JW, Cosgun SG, van Velzen MH, Janssen JA, Avazverdi N, Hovius SE, Walbeehm ET.

PLoS One. 2015 Jun 15;10(6):e0131144. doi: 10.1371/journal.pone.0131144. eCollection 2015. No abstract available.

38.

An early diagnostic tool for diabetic peripheral neuropathy in rats.

Kambiz S, van Neck JW, Cosgun SG, van Velzen MH, Janssen JA, Avazverdi N, Hovius SE, Walbeehm ET.

PLoS One. 2015 May 18;10(5):e0126892. doi: 10.1371/journal.pone.0126892. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131144.

39.

Changes in circulating IGF1 receptor stimulating activity do not parallel changes in total IGF1 during GH treatment of GH-deficient adults.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA.

Eur J Endocrinol. 2015 Aug;173(2):119-27. doi: 10.1530/EJE-15-0048. Epub 2015 May 6.

PMID:
25947141
40.

Maintaining warm, trusting relationships with brands: increased temperature perceptions after thinking of communal brands.

IJzerman H, Janssen JA, Coan JA.

PLoS One. 2015 Apr 27;10(4):e0125194. doi: 10.1371/journal.pone.0125194. eCollection 2015.

41.

IGF-IR Targeted Therapy: Past, Present and Future.

Janssen JA, Varewijck AJ.

Front Endocrinol (Lausanne). 2014 Dec 23;5:224. doi: 10.3389/fendo.2014.00224. eCollection 2014. Review.

42.

The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.

Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA.

J Clin Endocrinol Metab. 2015 Jan;100(1):309-16. doi: 10.1210/jc.2014-2558.

PMID:
25337924
43.

Smiles over time: an older adult oral health survey in Illinois.

Lukes SM, Janssen JA, Thacker KK, Wadhawan S.

J Dent Hyg. 2014 Aug;88(4):250-8.

PMID:
25134958
44.

Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.

Neggers SJ, Franck SE, de Rooij FW, Dallenga AH, Poublon RM, Feelders RA, Janssen JA, Buchfelder M, Hofland LJ, Jørgensen JO, van der Lely AJ.

J Clin Endocrinol Metab. 2014 Oct;99(10):3644-52. doi: 10.1210/jc.2014-2032. Epub 2014 Jun 17.

PMID:
24937542
45.

Insulin analogs and cancer: a note of caution.

Janssen JA, Varewijck AJ.

Front Endocrinol (Lausanne). 2014 May 26;5:79. doi: 10.3389/fendo.2014.00079. eCollection 2014. Review.

46.

Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.

De Martino MC, Feelders RA, de Herder WW, van Koetsveld PM, Dogan F, Janssen JA, Waaijers AM, Pivonello C, Lamberts SW, Colao A, de Krijger RR, Pivonello R, Hofland LJ.

Endocr Relat Cancer. 2014 Aug;21(4):601-13. doi: 10.1530/ERC-13-0112. Epub 2014 Jun 2.

PMID:
24891456
47.

Insulin-like growth factor-I receptor stimulating activity is associated with dementia.

de Bruijn RF, Janssen JA, Brugts MP, van Duijn CM, Hofman A, Koudstaal PJ, Ikram MA.

J Alzheimers Dis. 2014;42(1):137-42. doi: 10.3233/JAD-140186.

PMID:
24820016
48.

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life.

Varewijck AJ, van der Lely AJ, Neggers SJ, Lamberts SW, Hofland LJ, Janssen JA.

Endocr Connect. 2014 Apr 15;3(2):85-92. doi: 10.1530/EC-14-0028. Print 2014.

49.

The IGSF1 deficiency syndrome: characteristics of male and female patients.

Joustra SD, Schoenmakers N, Persani L, Campi I, Bonomi M, Radetti G, Beck-Peccoz P, Zhu H, Davis TM, Sun Y, Corssmit EP, Appelman-Dijkstra NM, Heinen CA, Pereira AM, Varewijck AJ, Janssen JA, Endert E, Hennekam RC, Lombardi MP, Mannens MM, Bak B, Bernard DJ, Breuning MH, Chatterjee K, Dattani MT, Oostdijk W, Biermasz NR, Wit JM, van Trotsenburg AS.

J Clin Endocrinol Metab. 2013 Dec;98(12):4942-52. doi: 10.1210/jc.2013-2743. Epub 2013 Oct 9.

PMID:
24108313
50.

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors.

van Adrichem RC, Hofland LJ, Feelders RA, De Martino MC, van Koetsveld PM, van Eijck CH, de Krijger RR, Sprij-Mooij DM, Janssen JA, de Herder WW.

Endocr Connect. 2013 Dec 1;2(4):172-7. doi: 10.1530/EC-13-0052. Print 2013.

Supplemental Content

Loading ...
Support Center